ArticleJournal of cellular and molecular medicine2025
RETRACTION: Positive Feedback in Cav-1-ROS Signalling in PSCs Mediates Metabolic Coupling between PSCs and Tumour Cells.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionS. Shao, T. Qin, W. Qian, Y. Yue, Y. Xiao, X. Li, D. Zhang, Z. Wang, Q. Ma, and J. Lei, "Positive Feedback in Cav-1-ROS Signalling in PSCs Mediates Metabolic Coupling between PSCs and Tumour Cells," Journal of Cellular and Molecular Medicine 24, no. 16 (2020): 9397-9408. https://doi.org/10.1111/jcmm.15596. The above article, published online on 07 July 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; and John Wiley & Sons Ltd. A third party reported that the BxPC-3 MCT4 bands in Figure 2G had been duplicated from another article by some of the same authors [Zhang et al. (2016); https://doi.org/10.18632/oncotarget.5677]. Both articles report these bands as originating from different experiments. In addition, the third party reported that the PSC TOMM20 and BxPC-3 PFKP bands in Figure 2F were duplicated and that the PSC beta-actin band in Figure 2G had been repeated as the beta-actin band in Figure 3G and as part of the PSC beta-actin bands in Figure 4D. An investigation by the publisher confirmed these concerns. The authors did not respond to an inquiry and request for original data by the publisher. The retraction has been agreed to because the evidence of image re-use and manipulation both with a previous article and within the same article fundamentally compromises the editors' confidence in the results presented. The authors did not respond to the notice regarding the retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.